Showing results (1-10 of 671) with videos related to

Sort By:
Pageof 68
Early Human Development|September 21, 2010
Challenges in immunisation against bacterial infection in childrenJohannes Trück, Andrew J Pollard
Expert Opinion on Biological Therapy|July 30, 2013
Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 yearsRuth Mitchell, Johannes Trück, Andrew J Pollard
Human Vaccines & Immunotherapeutics|March 18, 2014
Polysaccharide-specific B cell responses to vaccination in humansRuth Mitchell, Dominic F Kelly, Andrew J Pollard, et al.
Trends in Immunology|May 27, 2014
Studying the antibody repertoire after vaccination: practical applicationsJacob D Galson, Andrew J Pollard, Johannes Trück, et al.
The Pediatric Infectious Disease Journal|January 13, 2018
Differences in Immunization Site Pain in Toddlers Vaccinated With Either the 10- or the 13-Valent Pneumococcal Conjugate VaccineJohannes Trück, Sarah Kelly, Sena Jawad, et al.
The Journal of Infectious Diseases|December 5, 2013
The effect of chronic cytomegalovirus infection on pneumococcal vaccine responsesDaniel O'Connor, Johannes Trück, Rajeka Lazarus, et al.
Clinical Epigenetics|February 5, 2021
Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccinationSara Pischedda, Daniel O'Connor, Benjamin P Fairfax, et al.
Pageof 68